Showing results (591-600 of 614) with videos related to
Sort By:
Pageof 62
Medical Physics|September 28, 2025
A novel adaptive energy switching algorithm for proton arc therapy based on the machine-specific delivery characteristicsYujia Qian, Riao Dao, Lewei Zhao, et al.Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.Translational Psychiatry|October 25, 2018
Developmental protein kinase C hyper-activation results in microcephaly and behavioral abnormalities in zebrafishTaian Liu, Yujian Shi, Matthew T V Chan, et al.Nature Communications|December 2, 2021
Tumor evolution selectively inactivates the core microRNA machinery for immune evasionTian-Yu Song, Min Long, Hai-Xin Zhao, et al.Cancer|May 24, 2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal studyCanhua Xiao, Jonathan J Beitler, Gang Peng, et al.Annals of Hematology|November 12, 2025
Epstein-barr virus-encoded small RNA incorporated prognostic model enables precision risk stratification and guides treatment decisions in peripheral t-cell lymphoma: a multicenter retrospective cohortZe-Tao Chen, Ling Huang, Han-Guo Guo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2022
Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical TrialZhanjie Zhang, Bian Wu, Gang Peng, et al.International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.Oral Oncology|November 4, 2022
Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencingBian Wu, Liangfang Shen, Gang Peng, et al.Pregnancy Hypertension|September 5, 2018
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trialPeter von Dadelszen, Laura A Magee, Samantha J Benton, et al.Pageof 62